Transplantation Direct (Dec 2022)

Predictors of Length of Stay and Mortality During Simultaneous Liver-Kidney Transplant Index Admission: Results From the US-Multicenter SLKT Consortium

  • Pranab M. Barman, MD,
  • Yuval A. Patel, MD, MHS,
  • Jiaheng Xie, MS,
  • Min Zhang, PhD,
  • Jennifer Jo, MD,
  • Jasmine Sinha, MD, MPH,
  • Adeline Answine, MD, MBA,
  • Aaron Schluger, MD,
  • Kara Walter, MD,
  • Scott W. Biggins, MD,
  • Giuseppe Cullaro, MD,
  • Randi Wong, MS,
  • Jennifer C. Lai, MD, MBA,
  • Lisa B. VanWagner, MD, MS,
  • John Magee, MD,
  • Elizabeth C. Verna, MD,
  • Pratima Sharma, MD, MS

DOI
https://doi.org/10.1097/TXD.0000000000001408
Journal volume & issue
Vol. 8, no. 12
p. e1408

Abstract

Read online

Background. Length of stay (LOS) during index solid organ transplant impacts morbidity and healthcare costs. To date, there are no studies evaluating characteristics and outcomes of simultaneous liver-kidney transplant (SLKT) index hospitalization. We examined factors associated with LOS and mortality during index SLKT admission. Methods. Adult SLKT recipients between 2002 and 2017 at 6 transplant centers across 6 UNOS regions were retrospectively enrolled in the US-Multicenter SLKT Consortium. Multivariable regression analyses assessed predictors of SLKT LOS and death during index admission. Results. Median age of cohort (N = 570) was 58 y (interquartile range: 51–64); 63% male, 75% White, 32.3% hepatitis C, 23.3% alcohol-related, 20.1% nonalcoholic steatohepatitis with median MELD-Na at SLKT 28 (23–34). Seventy-one percent were hospitalized at the time of SLKT with median LOS pretransplant of 10 d. Majority of patients were discharged alive (N = 549; 96%)‚ and 36% were discharged to subacute rehab facility. LOS for index SLKT was 19 d (Q1: 10, Q3: 34 d). Female sex (P = 0.003), Black race (P = 0.02), advanced age (P = 0.007), ICU admission at time of SLKT (P = 0.03), high MELD-Na (P = 0.003), on cyclosporine during index hospitalization (P = 0.03), pre-SLKT dialysis (P 2 wk and affected overall patient survival. Further investigation is needed to optimize healthcare resources for these patients in a financially strained healthcare landscape.